REPASKIN FACIAL, BROAD SPECTRUM SPF 30 (Sesvalia USA LLC)
Welcome to the PulseAid listing for the REPASKIN FACIAL, BROAD SPECTRUM SPF 30 drug offered from Sesvalia USA LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sesvalia USA LLC |
NON-PROPRIETARY NAME: | OCTOCRYLENE, PHENYLBENZIMIDAZOLE SULFONIC ACID |
SUBSTANCE NAME: | OCTOCRYLENE; ENSULIZOLE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2014-04-04 |
END MARKETING DATE: | 0000-00-00 |
REPASKIN FACIAL, BROAD SPECTRUM SPF 30 HUMAN OTC DRUG Details:
Item Description | REPASKIN FACIAL, BROAD SPECTRUM SPF 30 from Sesvalia USA LLC |
LABELER NAME: | Sesvalia USA LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50; 20(mg/mL; mg/mL) |
START MARKETING DATE: | 2014-04-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63181-0010_1217d971-3111-46cc-a693-3a80bb531991 |
PRODUCT NDC: | 63181-0010 |
APPLICATION NUMBER: | part352 |
Other OCTOCRYLENE; ENSULIZOLE Pharmaceutical Manufacturers / Labelers: